Propelled by government investment and shareholder demand, manufacturers are pushing to get bio-based products into the marketplace. Made from plants, fungi, and microbes, these new materials aim to replace those that contain toxins and are difficult to recycle or reuse.
Just as in 2021, most European consulting firms did very well last year, with over 80% generating more profit in 2022 than in the previous year. When 29 consulting firms were asked what types of projects they had carried out, sales & operations planning (S&OP) scored the highest, followed by supply chain strategy projects and network optimization projects. Notably, there were several acquisitions in the consulting market over the past year, plus various proprietary software applications have been developed. All of these changes are visualized in the tenth edition of the SCM Consulting Subway Map of Europe.
As supply chain complexity increases and business disruptions grow more pronounced, supply chain education programs at the undergraduate and graduate level are responding to bolster the skill sets of upcoming and current supply chain practitioners.
The first step towards a more resilient supply chain is to map it in detail. Next, it is important to identify which parts of the supply chain are most vulnerable. To do this, businesses are increasingly using the approach MIT professor David Simchi-Levi introduced a decade ago. Supported by modern tools, his approach makes it possible to stress test any supply chain.
The next Target online order that ends up at your door might come from a new type of shipping facility aimed at making deliveries cheaper and faster.
As part of UMass Amherst’s ongoing partnership with the Kyiv School of Economics (KSE), Tymofiy Mylovanov, president of KSE, visited campus and met with UMass leaders on Feb. 22. Mylovanov has previously served as the minister of trade for Ukraine.
China’s growing influence over the world’s seaports is a geopolitical risk hidden in plain sight.
With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.
Beijing’s rapid U-turn on its zero-Covid policies created a gap in supplies of Pfizer, Merck medicines that health authorities are struggling to close
A total of 39% of EU zone citizens report difficulty paying their monthly bills
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578